Alnylam Pharmaceuticals

1,001 employees • 665 Concord Ave, Cambridge, MA, 02138, United States

Company Overview

Company Name

Alnylam Pharmaceuticals

Address

665 Concord Ave, Cambridge, MA, 02138, United States

Employees

1,001

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, with approximately 1,001 employees. The company focuses on developing RNAi therapeutics for the treatment of amyloidosis, hyperoxaluria, and porphyria, leveraging its proprietary delivery platforms and pipeline of clinical-stage programs.

Frequently Asked Questions about Alnylam Pharmaceuticals

Technologies Used

Social Profiles

Key Decision Makers

Vanessa Bahnam Clinical Trial Manager
LinkedIn
Nitender Goyal Director Clinical Research
LinkedIn
Weiyi Li Clinical Trial Manager
LinkedIn
Stephanie S. Clinical Trial Specialist
LinkedIn
Terry Maratos-Flier Director Clinical Research
LinkedIn
Melanie Keltz Clinical Trial Specialist
LinkedIn
Kenasha J. Manager, Clinical Operations
LinkedIn
Joseph Barry Associate Director, Data Sciences
LinkedIn
Jacob D Martin Clinical Trial Manager
LinkedIn
Jeremy Whitley, M.S. Clinical Trial Manager
LinkedIn
Sofia Moniz, MBA Clinical Trial Manager
LinkedIn
Rose M. Kaplan, MS, RD, LDN Clinical Trial Manager
LinkedIn
Laura Doyle Senior Director, Clinical Operations
LinkedIn